RPTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Repare Therapeutics Inc (RPTX).


$55.69M Market Cap.

As of 03/03/2025 5:00 PM ET (MRY) • Disclaimer

RPTX Market Cap. (MRY)


RPTX Shares Outstanding (MRY)


RPTX Assets (MRY)


Total Assets

$176.51M

Total Liabilities

$25.38M

Total Investments

$68.07M

RPTX Income (MRY)


Revenue

$53.48M

Net Income

-$84.69M

Operating Expense

$147.00M

RPTX Cash Flow (MRY)


CF Operations

-$76.44M

CF Investing

$49.47M

CF Financing

$542.00K

RPTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RPTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$176,506,000 (-30.48%)

$253,901,000 (-30.26%)

$364,075,000 (-1.26%)

$368,715,000 (3.26%)

Assets Current

$171,149,000 (-29.77%)

$243,688,000 (-31.16%)

$353,979,000 (0.73%)

$351,414,000 (1.40%)

Assets Non-Current

$5,357,000 (-47.55%)

$10,213,000 (1.16%)

$10,096,000 (-41.64%)

$17,301,000 (64.24%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$151,131,000 (-28.74%)

$212,082,000 (-24.13%)

$279,517,000 (-3.09%)

$288,421,000 (0.55%)

Property Plant & Equipment Net

$4,218,000 (-44.07%)

$7,541,000 (-21.44%)

$9,599,000 (-26.70%)

$13,095,000 (51.88%)

Cash & Equivalents

$84,717,000 (-23.86%)

$111,268,000 (-30.25%)

$159,521,000 (-52.30%)

$334,427,000 (2.46%)

Accumulated Other Comprehensive Income

$54,000 (92.86%)

$28,000 (106.54%)

-$428,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$11,952,000 (-78.57%)

$55,784,000 (8.25%)

$51,534,000 (-11.16%)

Total Investments

$68,074,000 (-39.41%)

$112,359,000 (-39.07%)

$184,420,000 (2379.10%)

$7,439,000 (-1.16%)

Investments Current

$68,074,000 (-39.41%)

$112,359,000 (-39.07%)

$184,420,000 (2379.10%)

$7,439,000 (-1.16%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,746,000 (-61.19%)

$4,499,000 (4.07%)

$4,323,000 (561.01%)

$654,000 (-84.25%)

Trade & Non-Trade Payables

$3,623,000 (50.96%)

$2,400,000 (420.61%)

$461,000 (-79.97%)

$2,302,000 (2.27%)

Accumulated Retained Earnings (Deficit)

-$417,798,000 (-25.42%)

-$333,109,000 (-39.19%)

-$239,313,000 (-13.81%)

-$210,266,000 (-103.43%)

Tax Assets

$11,560,000 (-11.68%)

$13,089,000 (0%)

$0 (0%)

$6,200,000 (81.13%)

Tax Liabilities

$0 (0%)

$0 (0%)

$1,240,000 (137.09%)

$523,000 (2805.56%)

Total Debt

$1,933,000 (-43.31%)

$3,410,000 (-37.18%)

$5,428,000 (-25.78%)

$7,313,000 (82.60%)

Debt Current

$1,845,000 (-23.13%)

$2,400,000 (10.55%)

$2,171,000 (26.15%)

$1,721,000 (146.92%)

Debt Non-Current

$88,000 (-91.29%)

$1,010,000 (-68.99%)

$3,257,000 (-41.76%)

$5,592,000 (69.04%)

Total Liabilities

$25,375,000 (-39.32%)

$41,819,000 (-50.54%)

$84,558,000 (5.31%)

$80,294,000 (14.29%)

Liabilities Current

$25,287,000 (-35.29%)

$39,079,000 (-50.29%)

$78,619,000 (124.06%)

$35,089,000 (218.59%)

Liabilities Non-Current

$88,000 (-96.79%)

$2,740,000 (-53.86%)

$5,939,000 (-86.86%)

$45,205,000 (-23.69%)

RPTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$53,477,000 (4.58%)

$51,133,000 (-61.21%)

$131,830,000 (1634.61%)

$7,600,000 (5529.63%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$29,680,000 (-12.10%)

$33,764,000 (3.70%)

$32,560,000 (24.21%)

$26,213,000 (82.72%)

Research & Development Expense

$115,941,000 (-13.21%)

$133,593,000 (12.20%)

$119,066,000 (32.23%)

$90,047,000 (124.61%)

Operating Expenses

$147,000,000 (-12.16%)

$167,357,000 (10.37%)

$151,626,000 (30.42%)

$116,260,000 (113.57%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$1,440,000 (115.35%)

-$9,383,000 (-161.95%)

$15,147,000 (1002.68%)

-$1,678,000 (-26.64%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$84,689,000 (9.71%)

-$93,796,000 (-222.91%)

-$29,047,000 (72.83%)

-$106,908,000 (-100.14%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$84,689,000 (9.71%)

-$93,796,000 (-222.91%)

-$29,047,000 (72.83%)

-$106,908,000 (-100.14%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$84,689,000 (9.71%)

-$93,796,000 (-222.91%)

-$29,047,000 (72.83%)

-$106,908,000 (-100.14%)

Weighted Average Shares

$42,411,085 (0.75%)

$42,093,293 (0.41%)

$41,922,042 (10.85%)

$37,818,115 (88.66%)

Weighted Average Shares Diluted

$42,411,085 (0.75%)

$42,093,293 (0.41%)

$41,922,042 (10.85%)

$37,818,115 (88.66%)

Earning Before Interest & Taxes (EBIT)

-$83,249,000 (19.32%)

-$103,179,000 (-642.29%)

-$13,900,000 (87.20%)

-$108,586,000 (-98.36%)

Gross Profit

$53,477,000 (4.58%)

$51,133,000 (-61.21%)

$131,830,000 (1634.61%)

$7,600,000 (5529.63%)

Operating Income

-$93,523,000 (19.53%)

-$116,224,000 (-487.11%)

-$19,796,000 (81.78%)

-$108,660,000 (-100.10%)

RPTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$49,468,000 (-36.61%)

$78,041,000 (144.40%)

-$175,778,000 (-10387.95%)

-$1,676,000 (82.83%)

Net Cash Flow from Financing

$542,000 (-35.63%)

$842,000 (-4.32%)

$880,000 (-99.08%)

$95,557,000 (-61.44%)

Net Cash Flow from Operations

-$76,445,000 (39.88%)

-$127,158,000 (-39590.06%)

$322,000 (100.38%)

-$85,796,000 (-1310.19%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$26,551,000 (44.98%)

-$48,253,000 (72.41%)

-$174,906,000 (-2277.89%)

$8,031,000 (-96.53%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$49,468,000 (-38.15%)

$79,979,000 (145.66%)

-$175,176,000 (-673653.85%)

-$26,000 (99.65%)

Capital Expenditure

$0 (0%)

-$1,938,000 (-221.93%)

-$602,000 (63.52%)

-$1,650,000 (26.24%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$542,000 (-35.63%)

$842,000 (-4.32%)

$880,000 (-99.08%)

$95,557,000 (-61.44%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$116,000 (-627.27%)

$22,000 (106.67%)

-$330,000 (-511.11%)

-$54,000 (91.06%)

Share Based Compensation

$23,170,000 (-7.55%)

$25,063,000 (27.28%)

$19,691,000 (53.49%)

$12,829,000 (405.68%)

Depreciation Amortization & Accretion

$4,280,000 (3.26%)

$4,145,000 (-0.93%)

$4,184,000 (25.12%)

$3,344,000 (87.13%)

RPTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-158.40% (13.63%)

-183.40% (-733.64%)

-22.00% (98.44%)

-1406.70% (96.44%)

EBITDA Margin

-147.70% (23.75%)

-193.70% (-2517.57%)

-7.40% (99.47%)

-1384.80% (96.47%)

Return on Average Equity (ROAE)

-44.50% (-11.81%)

-39.80% (-265.14%)

-10.90% (73.99%)

-41.90% (-65.61%)

Return on Average Assets (ROAA)

-38.40% (-20.75%)

-31.80% (-287.80%)

-8.20% (74.61%)

-32.30% (-81.46%)

Return on Sales (ROS)

-155.70% (22.84%)

-201.80% (-1821.90%)

-10.50% (99.27%)

-1428.80% (96.48%)

Return on Invested Capital (ROIC)

-78.50% (1.63%)

-79.80% (-377.84%)

-16.70% (98.02%)

-842.70% (-75.09%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.66 (79.99%)

-3.27 (84.64%)

-21.32 (-186.08%)

-7.45 (42.21%)

Price to Sales Ratio (P/S)

1.04 (-82.71%)

6.01 (28.45%)

4.68 (-95.54%)

104.94 (-97.94%)

Price to Book Ratio (P/B)

0.37 (-74.62%)

1.45 (-34.33%)

2.21 (-27.65%)

3.05 (-30.57%)

Debt to Equity Ratio (D/E)

0.17 (-14.72%)

0.2 (-34.98%)

0.3 (8.99%)

0.28 (13.47%)

Earnings Per Share (EPS)

-2 (10.31%)

-2.23 (-223.19%)

-0.69 (75.62%)

-2.83 (-6.39%)

Sales Per Share (SPS)

1.26 (3.79%)

1.22 (-61.37%)

3.15 (1464.68%)

0.2 (2771.43%)

Free Cash Flow Per Share (FCFPS)

-1.8 (41.25%)

-3.07 (-43714.29%)

-0.01 (99.70%)

-2.31 (-457.11%)

Book Value Per Share (BVPS)

3.56 (-29.28%)

5.04 (-24.45%)

6.67 (-12.57%)

7.63 (-46.70%)

Tangible Assets Book Value Per Share (TABVPS)

4.16 (-31.00%)

6.03 (-30.55%)

8.69 (-10.92%)

9.75 (-45.27%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-2 (94.12%)

-34 (-466.67%)

-6 (64.71%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.28 (113.68%)

-2.06 (95.72%)

-48.16 (-709.34%)

-5.95 (65.63%)

Asset Turnover

0.24 (39.66%)

0.17 (-53.23%)

0.37 (1517.39%)

0.02 (0%)

Current Ratio

6.77 (8.53%)

6.24 (38.52%)

4.5 (-55.05%)

10.02 (-68.17%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$76,445,000 (40.78%)

-$129,096,000 (-46005.71%)

-$280,000 (99.68%)

-$87,446,000 (-950.91%)

Enterprise Value (EV)

-$22,288,973 (-110.92%)

$204,101,452 (-56.38%)

$467,956,812 (-25.28%)

$626,278,352 (-31.70%)

Earnings Before Tax (EBT)

-$83,249,000 (19.32%)

-$103,179,000 (-642.29%)

-$13,900,000 (87.20%)

-$108,586,000 (-98.36%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$78,969,000 (20.26%)

-$99,034,000 (-919.29%)

-$9,716,000 (90.77%)

-$105,242,000 (-98.74%)

Invested Capital

$68,435,000 (-36.02%)

$106,964,000 (-18.57%)

$131,363,000 (1917.25%)

$6,512,000 (-72.50%)

Working Capital

$145,862,000 (-28.71%)

$204,609,000 (-25.69%)

$275,360,000 (-12.95%)

$316,325,000 (-5.73%)

Tangible Asset Value

$176,506,000 (-30.48%)

$253,901,000 (-30.26%)

$364,075,000 (-1.26%)

$368,715,000 (3.26%)

Market Capitalization

$55,689,027 (-81.89%)

$307,546,452 (-50.18%)

$617,253,812 (-29.87%)

$880,192,352 (-30.20%)

Average Equity

$190,430,000 (-19.15%)

$235,527,000 (-11.91%)

$267,367,500 (4.91%)

$254,854,000 (20.91%)

Average Assets

$220,330,750 (-25.20%)

$294,550,500 (-16.94%)

$354,606,500 (7.13%)

$331,019,750 (10.10%)

Invested Capital Average

$106,022,000 (-18.01%)

$129,309,500 (55.00%)

$83,423,500 (547.41%)

$12,885,750 (13.29%)

Shares

42,510,708 (0.90%)

42,129,651 (0.40%)

41,961,510 (0.54%)

41,735,057 (13.52%)